Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer.

Auteurs

Captier N, Lerousseau M, Orlhac F, Hovhannisyan-Baghdasarian N, Luporsi M, Woff E, Lagha S, Salamoun Feghali P, Lonjou C, Beaulaton C, Zinovyev A, Salmon H, Walter T, Buvat I, Girard N, Barillot E

  • Date de publication

    Januari 2025

  • Type

    Article

  • Tijdschrift

    Nat Commun

  • Naam van de onderzoeker

    WOFF ERWIN

  • Hôpital

    Institut Jules Bordet

  • Dienst

    Médecine nucléaire IJB

  • PMID

    39800784

  • DOI

    10.1038/s41467-025-55847-5